Reporting standards for studies of diagnostic test accuracy in dementia The STARDdem Initiative

被引：143

作者：

Noel-Storr, Anna H. ^{[1
]}

McCleery, Jenny M. ^{[1
]}

Richard, Edo ^{[4
]}

Ritchie, Craig W. ^{[6
]}

Flicker, Leon ^{[7
]}

Cullum, Sarah J. ^{[8
]}

Davis, Daniel ^{[9
]}

Quinn, Terence J. ^{[10
]}

Hyde, Chris ^{[11
]}

Rutjes, Anne W. S. ^{[12
]}

Smailagic, Nadja ^{[1
]}

Marcus, Sue ^{[1
]}

Black, Sandra ^{[13
]}

Blennow, Kaj ^{[14
]}

Brayne, Carol ^{[9
]}

Fiorivanti, Mario ^{[15
]}

Johnson, Julene K. ^{[16
,17
,18
,19
]}

Koepke, Sascha ^{[20
]}

Schneider, Lon S. ^{[21
]}

Simmons, Andrew ^{[22
]}

Mattsson, Niklas ^{[14
]}

Zetterberg, Henrik ^{[14
]}

Bossuyt, Patrick M. M. ^{[5
]}

Wilcock, Gordon ^{[2
]}

McShane, Rupert ^{[3
]}

机构：

[1] Univ Oxford, Cochrane Dementia & Cognit Improvement Grp, Oxford OX1 2JD, England

[2] Univ Oxford, Dept Geratol, Nuffield Dept Clin Neurosci, Oxford OX1 2JD, England

[3] Univ Oxford, Dept Psychiat, Oxford OX1 2JD, England

[4] Univ Amsterdam, Dept Neurol, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands

[5] Univ Amsterdam, Dept Clin Epidemiol & Biostat, NL-1012 WX Amsterdam, Netherlands

[6] Imperial Coll London, Ctr Mental Hlth, London, England

[7] Univ Western Australia, Western Australian Inst Med Res, Western Australian Ctr Hlth & Ageing WACHA, Perth, WA 6009, Australia

[8] Univ Bristol, Sch Social & Community Med, Ctr Acad Mental Hlth, Bristol BS8 1TH, Avon, England

[9] Univ Cambridge, Inst Publ Hlth, Cambridge CB2 1TN, England

[10] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland

[11] Univ Exeter, Peninsula Technol Assessment Grp PenTAG, Exeter EX4 4QJ, Devon, England

[12] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland

[13] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada

[14] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Molndal, Sweden

[15] Univ Roma La Sapienza, Dept Neurol & Psychiat, I-00185 Rome, Italy

[16] Univ Calif San Francisco, Inst Hlth & Aging, Dept Social & Behav Sci, San Francisco, CA 94143 USA

[17] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA

[18] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA

[19] Univ Calif San Francisco, Dept Biomed Imaging, San Francisco, CA 94143 USA

[20] Univ Lubeck, Inst Social Med & Epidemiol, Nursing Res Grp, Lubeck, Germany

[21] Univ So Calif, Keck Sch Med, Dept Psychiat Neurol & Gerontol, Los Angeles, CA 90089 USA

[22] Kings Coll London, Inst Psychiat, Dept Neuroimaging, London WC2R 2LS, England

来源：

NEUROLOGY | 2014年 / 83卷 / 04期

关键词：

ALZHEIMERS ASSOCIATION WORKGROUPS; NATIONAL INSTITUTE; COGNITIVE IMPAIRMENT; SPINAL-FLUID; GUIDELINES; DISEASE; RECOMMENDATIONS; BIOMARKERS; QUALITY; EXPLANATION;

D O I：

10.1212/WNL.0000000000000621

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Objective: To provide guidance on standards for reporting studies of diagnostic test accuracy for dementia disorders. Methods: An international consensus process on reporting standards in dementia and cognitive impairment (STARDdem) was established, focusing on studies presenting data from which sensitivity and specificity were reported or could be derived. A working group led the initiative through 4 rounds of consensus work, using a modified Delphi process and culminating in a face-to-face consensus meeting in October 2012. The aim of this process was to agree on how best to supplement the generic standards of the STARD statement to enhance their utility and encourage their use in dementia research. Results: More than 200 comments were received during the wider consultation rounds. The areas at most risk of inadequate reporting were identified and a set of dementia-specific recommendations to supplement the STARD guidance were developed, including better reporting of patient selection, the reference standard used, avoidance of circularity, and reporting of test-retest reliability. Conclusion: STARDdem is an implementation of the STARD statement in which the original checklist is elaborated and supplemented with guidance pertinent to studies of cognitive disorders. Its adoption is expected to increase transparency, enable more effective evaluation of diagnostic tests in Alzheimer disease and dementia, contribute to greater adherence to methodologic standards, and advance the development of Alzheimer biomarkers.

引用

页码：364 / 373

页数：10

共 33 条

[31] Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative [J].

Vanderstichele, Hugo ;

Bibl, Mirko ;

Engelborghs, Sebastiaan ;

Le Bastard, Nathalie ;

Lewczuk, Piotr ;

Molinuevo, Jose Luis ;

Parnetti, Lucilla ;

Perret-Liaudet, Armand ;

Shaw, Leslie M. ;

Teunissen, Charlotte ;

Wouters, Dirk ;

Blennow, Kaj .

ALZHEIMERS & DEMENTIA, 2012, 8 (01) :65-73

[32] A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease [J].

Verwey, N. A. ;

van der Flier, W. M. ;

Blennow, K. ;

Clark, C. ;

Sokolow, S. ;

De Deyn, P. P. ;

Galasko, D. ;

Hampel, H. ;

Hartmann, T. ;

Kapaki, E. ;

Lannfelt, L. ;

Mehta, P. D. ;

Parnetti, L. ;

Petzold, A. ;

Pirttila, T. ;

Salieh, L. ;

Skinningsrud, A. ;

v Swieten, J. C. ;

Verbeek, M. M. ;

Wiltfang, J. ;

Younkin, S. ;

Scheltens, P. ;

Blankenstein, M. A. .

ANNALS OF CLINICAL BIOCHEMISTRY, 2009, 46 :235-240

[33] Why Current Publication Practices May Distort Science [J].

Young, Neal S. ;

Ioannidis, John P. A. ;

Al-Ubaydi, Omar .

PLOS MEDICINE, 2008, 5 (10) :1418-1422

← 1 2 3 4 →